Methylpropyltryptamine
| Names | |
|---|---|
| Preferred IUPAC name
N-[2-(1H-Indol-3-yl)ethyl]-N-methylpropan-1-amine | |
| Other names
N-Methyl-N-propyltryptamine | |
| Identifiers | |
3D model (JSmol) |
|
| ChemSpider | |
PubChem CID |
|
| UNII | |
| |
| |
| Properties | |
| C14H20N2 | |
| Molar mass | 216.328 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
Methylpropyltryptamine (MPT; N-methyl-N-propyltryptamine) is a tryptamine. It is a homologue of methylethyltryptamine (MET). In TiHKAL, Alexander Shulgin described MPT's effects as being unknown and its dosage as being >50 mg.
An analytical method for MPT's detection has been reported. In 2019, Chadeayne et al. published the crystal structure of MPT. The authors describe the structure as "...a single molecule in the asymmetric unit, with an indole group that demonstrates a mean deviation from planarity of 0.015 A°."